Abstract
We investigated the mechanisms of excitation-contraction (EC) coupling in human embryonic stem cell-derived cardiomyocytes (hESC-CMs) and fetal ventricular myocytes (hFVMs) using patch-clamp electrophysiology and confocal microscopy. We tested the hypothesis that Ca2+ influx via voltage-gated L-type Ca2+ channels activates Ca2+ release from the sarcoplasmic reticulum (SR) via a local control mechanism in hESC-CMs and hFVMs. Field-stimulated, whole-cell [Ca2+]i transients in hESC-CMs required Ca2+ entry through L-type Ca2+ channels, as evidenced by the elimination of such transients by either removal of extracellular Ca2+ or treatment with diltiazem, an L-type channel inhibitor. Ca2+ release from the SR also contributes to the [Ca2+]i transient in these cells, as evidenced by studies with drugs interfering with either SR Ca2+ release (i.e. ryanodine and caffeine) or reuptake (i.e. thapsigargin and cyclopiazonic acid). As in adult ventricular myocytes, membrane depolarization evoked large L-type Ca2+ currents (I Ca) and corresponding whole-cell [Ca2+]i transients in hESC-CMs and hFVMs, and the amplitude of both I Ca and the [Ca2+]i transients were finely graded by the magnitude of the depolarization. hESC-CMs exhibit a decreasing EC coupling gain with depolarization to more positive test potentials, “tail” [Ca2+]i transients upon repolarization from extremely positive test potentials, and co-localized ryanodine and sarcolemmal L-type Ca2+ channels, all findings that are consistent with the local control hypothesis. Finally, we recorded Ca2+ sparks in hESC-CMs and hFVMs. Collectively, these data support a model in which tight, local control of SR Ca2+ release by the I Ca during EC coupling develops early in human cardiomyocytes.
Highlights
IntroductionHuman embryonic stem cells (hESCs) can be induced to differentiate in vitro into cardiomyocytes (hESC-CMs)
Human embryonic stem cells can be induced to differentiate in vitro into cardiomyocytes
We examined the mechanisms of EC coupling in Human embryonic stem cells (hESCs)-CMs, as well as in,100 day old human fetal ventricular myocytes, which serve as a useful comparison cell type of known age
Summary
Human embryonic stem cells (hESCs) can be induced to differentiate in vitro into cardiomyocytes (hESC-CMs). These cells express expected cardiac markers and exhibit spontaneous action potentials (APs), [Ca2+]i transients, and contractile activity. The mechanisms underlying excitation-contraction (EC) coupling in hESC-CMs are incompletely understood. HESC-CMs represent a unique model system in which to study the development of EC coupling in early human myocardium. Because of their tremendous expandability and unquestioned cardiac potential, hESC-CMs have considerable promise for eventual application in cell-based cardiac repair (for review, see refs [1,2]). Because hESC-CMs should be well-matched to host adult human ventricular myocardium to optimize hostgraft electromechanical integration and minimize the risk of arrhythmias, the development of any cell therapies based on hESC-CMs must be preceded by a thorough investigation of the biophysical properties of these cells
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.